Bottom line: GLP-1 RAs can affect your electrolyte balance through multiple pathways both directly (by changing how your body processes sodium and insulin) and indirectly (by reducing your food and fluid intake or causing GI side effects)
Common GLP-1 Side Effects Commonly reported semaglutide side effects include: Nausea Vomiting Diarrhea Constipation Abdominal pain Reduced appetite Bloating or fullness Indigestion Dizziness Fatigue Symptoms, Possible Concerns, and Related Tests Safety note: Severe abdominal pain, inability to keep fluids down, very low urine output, jaundice, facial or throat swelling, difficulty breathing, confusion, or sudden vision changes should not wait for routine outpatient lab testing
Bottom line Retatrutide is still in clinical trials, with early data suggesting significant weight loss potential, while tirzepatide has FDA approval and proven efficacy and safety history
To be on the safe side: Even if you've used Mounjaro before, a new medicine will usually mean a fresh titration schedule (if and when it's approved), because tolerability matters
By acting on both GLP-1 and GIP receptors, it enhances insulin secretion and reduces appetite, making it a promising option for those seeking better health control
You might feel hungry an hour after a meal instead of coasting until the next one
